Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

269
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
269
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Developing and Validating a Risk Model for Severe Bone Marrow Suppression in Esophageal Cancer Treated with Radiotherapy or Chemoradiotherapy: A Retrospective Cohort Study.

Technology in cancer research & treatment·2026
Same author

Shogaol triggers apoptosis and ferroptosis in Ewing sarcoma by targeting the polo-like kinase 1/nucleophosmin 1 axis.

Free radical biology & medicine·2026
Same author

ELK1 promotes the progress of myeloid leukemia by hindering the differentiation of neutrophils.

Experimental hematology & oncology·2026
Same author

TNFSF10 drives hyperactive immune responses via NLRP3 inflammasome and endoplasmic reticulum stress in autoimmune and inflammatory diseases.

Journal of advanced research·2026
Same author

Clinical Impact of MTAP Rearrangement in Pediatric Acute Lymphoblastic Leukemia: Insights From Whole Transcriptome Analysis.

Pediatric blood & cancer·2025
Same author

Matrix-bound nanovesicles drive the engineering of immunomodulatory meshes for abdominal hernia repair.

Biomaterials advances·2025

相关实验视频

Updated: May 22, 2025

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.4K

在血液性恶性瘤中,TRAIL的基础和应用研究进展.

Sidong Zhang1, Rongqun Guo2, Yufeng Liu1

  • 1Department of Pediatric Hematology-Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Blood science (Baltimore, Md.)
|March 14, 2025
PubMed
概括

本综述探讨了与瘤坏死因子相关的诱导亡的连接物 (TRAIL) 对于血液癌症. 它讨论了 TRAIL 的问题.

关键词:
临床应用 临床应用药物耐受性 药物耐受性血液性恶性瘤 血液性恶性瘤轨道的轨道是一个轨道.

更多相关视频

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

874
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.1K

相关实验视频

Last Updated: May 22, 2025

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.4K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

874
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.1K

科学领域:

  • 血液学 血液学 血液学
  • 癌症生物学 癌症生物学
  • 免疫学 免疫学 免疫学

背景情况:

  • 血液性恶性瘤是各种血液癌症,存在复发和抵抗等持续挑战.
  • 世界卫生组织的分类有助于了解癌症生物学和遗传研究.
  • 与瘤坏死因子相关的诱导亡的连接体 (TRAIL) 显示出诱导癌细胞死亡的前景.

研究的目的:

  • 审查血液性恶性瘤中TRAIL机制.
  • 为了确定有助于TRAIL抗性的因素.
  • 为突出提高血癌中基于 TRAIL 的治疗方法的策略.

主要方法:

  • 在血液恶性瘤中对TRAIL的临床前和临床研究的文献综述.
  • 分析 TRAIL 信号通路和阻力机制.
  • 检查当前的治疗策略和未来的方向.

主要成果:

  • TRAIL诱导癌细胞的亡,但由于瘤异质性和耐药性而面临限制.
  • 了解 TRAIL 耐药性机制对于有效治疗至关重要.
  • 目前正在研究各种策略来克服 TRAIL 阻力.

结论:

  • TRAIL仍然是血液恶性瘤的有前途的治疗点.
  • 克服阻力是实现TRAIL充分临床潜力的关键.
  • 需要进一步的研究来优化基于 TRAIL 的疗法,以改善患者的治疗结果.